Values exclude supplementation dose. Muscle strength and Poziotinib supplier resistance exercise volume There were no significant differences

in the 1-RM values between legs at each testing session for the angled leg press (p = 0.35) and leg R428 in vitro extension (p = 0.42) exercises. The 1-RM for the leg press was 156.05 ± 18.86 kg for the right leg and 154.29 ± 25.52 kg for the left leg, and the 1-RM for the leg extension was 44.94 ± 3.91 kg for the right leg and 44.69 ± 5.11 kg for the left leg. Additionally, there were no significant differences in the resistance exercise volume between the two testing sessions. The volume for leg press was 4744.5 ± 960.4 kg for WP and 4841.6 ± 1212.9

kg for CHO (p = 0.89), and the volume for leg extension was 1187.5 ± 267.6 kg for WP and 1285.2 ± 180.1 kg for CHO (p = 0.35). Serum IGF-1 and insulin For IGF-1, no significant main effects for Supplement and Test or the Supplement × Test interaction were observed (p > 0.05) (Table 3). For insulin, no significant main effect for Supplement or the Adriamycin research buy Supplement × Test interaction was observed (p > 0.05); although, a significant main effect for Test (p < 0.001) was observed. Post-hoc analysis showed significant differences between baseline, 30 min post-supplement ingestion, 15 min post-exercise, and 120 min post-exercise (Table 3). Table 3 Serum IGF-1 and insulin levels for WP and CHO. Variable Time Point WP CHO p-value IGF-1 (ng/ml) Baseline

0.46 ± 0.4 0.39 ± 0.3 Supplement (S) = 0.64   30 min Glycogen branching enzyme post-ingestion 0.47 ± 0.4 0.45 ± 0.4 Test (T) = 0.34   15 min post-exercise 0.44 ± 0.5 0.39 ± 0.3 S × T = 0.89   120 min post-exercise 0.50 ± 0.4 0.44 ± 0.3   Insulin (μIU/ml) Baseline 12.83 ± 6.1 14.05 ± 7.1 Supplement (S) = 0.95   30 min post-ingestion 51.90 ± 25.3 50.59 ± 34.9 Test (T) = 0.001†¥#   15 min post-exercise 23.60 ± 14.1 14.62 ± 8.9 S × T = 0.76   120 min post-exercise 10.08 ± 6.5 9.33 ± 5.5   Data are means ± standard deviations. † represents significant difference from baseline at 30 min post-ingestion. ¥ represents significant difference from baseline at 15 min post-exercise. # represents significant difference from baseline at 120 min post-exercise. Akt/mTOR signaling intermediates While no significant main effects for Supplement or the Supplement × Test interaction were observed for any of the variables (p > 0.05), a significant main effect for Test (p < 0.05) was observed for IRS-1 (p = 0.040), mTOR (p = 0.002), p70S6K (p = 0.046), and 4E-BP1 (p = 0.001). No significant main effects for Test was observed for Akt (p = 0.359). Subsequent analyses revealed a significant increase from baseline in IRS-1 at 15 and 120 m post-exercise, an increase in mTOR and p70S6K at 15 min post-exercise, and a significant decrease in 4E-BP1 at 15 min post-exercise (Table 4).